{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:41:45Z","timestamp":1767894105789,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["H18C1178"],"award-info":[{"award-number":["H18C1178"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13287-018-1100-1","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T02:06:37Z","timestamp":1546049197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Recapitulation of methotrexate hepatotoxicity with induced pluripotent stem cell-derived hepatocytes from patients with rheumatoid arthritis"],"prefix":"10.1186","volume":"9","author":[{"given":"Juryun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yena","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhyeok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyerin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kijun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaewoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeri Alice","family":"Rim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoojun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyeon","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,29]]},"reference":[{"key":"1100_CR1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1517\/13543784.2012.690029","volume":"21","author":"K Vaddi","year":"2012","unstructured":"Vaddi K, Luchi M. JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy. Expert Opin Investig Drugs. 2012;21:961\u201373.","journal-title":"Expert Opin Investig Drugs"},{"key":"1100_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"JA Wessels","year":"2008","unstructured":"Wessels JA, Huizinga TW, Guchelaar HJ. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2008;47:249\u201355.","journal-title":"Rheumatology (Oxford)"},{"key":"1100_CR3","first-page":"168","volume":"65","author":"H Tian","year":"2007","unstructured":"Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2007;65:168\u201373.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"1100_CR4","first-page":"104","volume":"2","author":"R Sotoudehmanesh","year":"2010","unstructured":"Sotoudehmanesh R, Anvari B, Akhlaghi M, Shahraeeni S, Kolahdoozan S. Methotrexate hepatotoxicity in patients with rheumatoid arthritis. Middle East J Dig Dis. 2010;2:104\u20139.","journal-title":"Middle East J Dig Dis"},{"key":"1100_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrrheum.2010.214","volume":"7","author":"GP Aithal","year":"2011","unstructured":"Aithal GP. Hepatotoxicity related to antirheumatic drugs. Nat Rev Rheumatol. 2011;7:139\u201350.","journal-title":"Nat Rev Rheumatol"},{"key":"1100_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1039\/C2TX20051A","volume":"2","author":"VY Soldatow","year":"2013","unstructured":"Soldatow VY, Lecluyse EL, Griffith LG, Rusyn I. In vitro models for liver toxicity testing. Toxicol Res (Camb). 2013;2:23\u201339.","journal-title":"Toxicol Res (Camb)"},{"key":"1100_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00204-014-1265-z","volume":"88","author":"AK Sjogren","year":"2014","unstructured":"Sjogren AK, Liljevald M, Glinghammar B, Sagemark J, Li XQ, Jonebring A, Cotgreave I, Brolen G, Andersson TB. Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes. Arch Toxicol. 2014;88:1427\u201337.","journal-title":"Arch Toxicol"},{"key":"1100_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"1100_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.stem.2014.01.008","volume":"14","author":"Y Du","year":"2014","unstructured":"Du Y, Wang J, Jia J, Song N, Xiang C, Xu J, Hou Z, Su X, Liu B, Jiang T, et al. Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell. 2014;14:394\u2013403.","journal-title":"Cell Stem Cell"},{"key":"1100_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5966\/sctm.2012-0160","volume":"2","author":"X Ma","year":"2013","unstructured":"Ma X, Duan Y, Tschudy-Seney B, Roll G, Behbahan IS, Ahuja TP, Tolstikov V, Wang C, McGee J, Khoobyari S, et al. Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells. Stem Cells Transl Med. 2013;2:409\u201319.","journal-title":"Stem Cells Transl Med"},{"key":"1100_CR11","first-page":"349","volume":"19","author":"MD Davidson","year":"2015","unstructured":"Davidson MD, Ware BR, Khetani SR. Stem cell-derived liver cells for drug testing and disease modeling. Discov Med. 2015;19:349\u201358.","journal-title":"Discov Med"},{"key":"1100_CR12","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1073\/pnas.1121400109","volume":"109","author":"RE Schwartz","year":"2012","unstructured":"Schwartz RE, Trehan K, Andrus L, Sheahan TP, Ploss A, Duncan SA, Rice CM, Bhatia SN. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109:2544\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1100_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2017;16:115\u201330.","journal-title":"Nat Rev Drug Discov"},{"key":"1100_CR14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrd3577","volume":"10","author":"M Grskovic","year":"2011","unstructured":"Grskovic M, Javaherian A, Strulovici B, Daley GQ. Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov. 2011;10:915\u201329.","journal-title":"Nat Rev Drug Discov"},{"key":"1100_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/clpt.2011.9","volume":"89","author":"BD Anson","year":"2011","unstructured":"Anson BD, Kolaja KL, Kamp TJ. Opportunities for use of human iPS cells in predictive toxicology. Clin Pharmacol Ther. 2011;89:754\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"1100_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.23354","volume":"51","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2010;51:297\u2013305.","journal-title":"Hepatology"},{"key":"1100_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nprot.2012.153","volume":"8","author":"NR Hannan","year":"2013","unstructured":"Hannan NR, Segeritz CP, Touboul T, Vallier L. Production of hepatocyte-like cells from human pluripotent stem cells. Nat Protoc. 2013;8:430\u20137.","journal-title":"Nat Protoc"},{"key":"1100_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/hep.24790","volume":"55","author":"YF Chen","year":"2012","unstructured":"Chen YF, Tseng CY, Wang HW, Kuo HC, Yang VW, Lee OK. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology. 2012;55:1193\u2013203.","journal-title":"Hepatology"},{"key":"1100_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5966\/sctm.2013-0146","volume":"3","author":"D Szkolnicka","year":"2014","unstructured":"Szkolnicka D, Farnworth SL, Lucendo-Villarin B, Storck C, Zhou W, Iredale JP, Flint O, Hay DC. Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med. 2014;3:141\u20138.","journal-title":"Stem Cells Transl Med"},{"key":"1100_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.stemcr.2015.04.001","volume":"4","author":"R Siller","year":"2015","unstructured":"Siller R, Greenhough S, Naumovska E, Sullivan GJ. Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells. Stem Cell Reports. 2015;4:939\u201352.","journal-title":"Stem Cell Reports"},{"key":"1100_CR21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nchembio.1270","volume":"9","author":"J Shan","year":"2013","unstructured":"Shan J, Schwartz RE, Ross NT, Logan DJ, Thomas D, Duncan SA, North TE, Goessling W, Carpenter AE, Bhatia SN. Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol. 2013;9:514\u201320.","journal-title":"Nat Chem Biol"},{"key":"1100_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086372","volume":"9","author":"RL Gieseck 3rd","year":"2014","unstructured":"Gieseck RL 3rd, Hannan NR, Bort R, Hanley NA, Drake RA, Cameron GW, Wynn TA, Vallier L. Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS One. 2014;9:e86372.","journal-title":"PLoS One"},{"key":"1100_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nbt.3377","volume":"33","author":"G Levy","year":"2015","unstructured":"Levy G, Bomze D, Heinz S, Ramachandran SD, Noerenberg A, Cohen M, Shibolet O, Sklan E, Braspenning J, Nahmias Y. Long-term culture and expansion of primary human hepatocytes. Nat Biotechnol. 2015;33:1264.","journal-title":"Nat Biotechnol"},{"key":"1100_CR24","first-page":"1329459","volume":"2016","author":"Y Kim","year":"2016","unstructured":"Kim Y, Rim YA, Yi H, Park N, Park SH, Ju JH. The generation of human induced pluripotent stem cells from blood cells: an efficient protocol using serial plating of reprogrammed cells by centrifugation. Stem Cells Int. 2016;2016:1329459.","journal-title":"Stem Cells Int"},{"key":"1100_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nprot.2014.020","volume":"9","author":"T Takebe","year":"2014","unstructured":"Takebe T, Zhang RR, Koike H, Kimura M, Yoshizawa E, Enomura M, Koike N, Sekine K, Taniguchi H. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc. 2014;9:396\u2013409.","journal-title":"Nat Protoc"},{"key":"1100_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jcyt.2014.01.006","volume":"16","author":"DC Bartlett","year":"2014","unstructured":"Bartlett DC, Hodson J, Bhogal RH, Youster J, Newsome PN. Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver. Cytotherapy. 2014;16:800\u20139.","journal-title":"Cytotherapy"},{"key":"1100_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","volume":"14","author":"P Huang","year":"2014","unstructured":"Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z, Cen J, Chen X, Liu C, Hu Y, et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell. 2014;14:370\u201384.","journal-title":"Cell Stem Cell"},{"key":"1100_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","volume":"13","author":"BN Cronstein","year":"2017","unstructured":"Cronstein BN, Sitkovsky M. Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol. 2017;13:41\u201351.","journal-title":"Nat Rev Rheumatol"},{"key":"1100_CR29","first-page":"943","volume":"35","author":"EL Houlder","year":"2017","unstructured":"Houlder EL, Millier MJ, Highton J, Gwynne-Jones D, Stamp LK, Hessian PA. Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules. Clin Exp Rheumatol. 2017;35:943\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"1100_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/1751-2980.12184","volume":"15","author":"RK Bath","year":"2014","unstructured":"Bath RK, Brar NK, Forouhar FA, Wu GY. A review of methotrexate-associated hepatotoxicity. J Dig Dis. 2014;15:517\u201324.","journal-title":"J Dig Dis"},{"key":"1100_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/toxsci\/kfs122","volume":"127","author":"SJ Fey","year":"2012","unstructured":"Fey SJ, Wrzesinski K. Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line. Toxicol Sci. 2012;127:403\u201311.","journal-title":"Toxicol Sci"},{"key":"1100_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5009\/gnl16010","volume":"11","author":"H Jeon","year":"2017","unstructured":"Jeon H, Kang K, Park SA, Kim WD, Paik SS, Lee SH, Jeong J, Choi D. Generation of multilayered 3D structures of HepG2 cells using a bio-printing technique. Gut Liver. 2017;11:121\u20138.","journal-title":"Gut Liver"},{"key":"1100_CR33","first-page":"1759","volume":"40","author":"F Meier","year":"2017","unstructured":"Meier F, Freyer N, Brzeszczynska J, Knospel F, Armstrong L, Lako M, Greuel S, Damm G, Ludwig-Schwellinger E, Deschl U, et al. Hepatic differentiation of human iPSCs in different 3D models: a comparative study. Int J Mol Med. 2017;40:1759\u201371.","journal-title":"Int J Mol Med"},{"key":"1100_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep21174","volume":"6","author":"A Takai","year":"2016","unstructured":"Takai A, Fako V, Dang H, Forgues M, Yu Z, Budhu A, Wang XW. Three-dimensional organotypic culture models of human hepatocellular carcinoma. Sci Rep. 2016;6:21174.","journal-title":"Sci Rep"},{"key":"1100_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep41238","volume":"7","author":"Y Choudhury","year":"2017","unstructured":"Choudhury Y, Toh YC, Xing J, Qu Y, Poh J, Huan L, Tan HS, Kanesvaran R, Yu H, Tan MH. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity. Sci Rep. 2017;7:41238.","journal-title":"Sci Rep"},{"key":"1100_CR36","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI43122","volume":"120","author":"ST Rashid","year":"2010","unstructured":"Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, Huang-Doran I, Griffin J, Ahrlund-Richter L, Skepper J, et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest. 2010;120:3127\u201336.","journal-title":"J Clin Invest"},{"key":"1100_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.scr.2018.02.017","volume":"29","author":"F Griscelli","year":"2018","unstructured":"Griscelli F, Ezanno H, Soubeyrand M, Feraud O, Oudrhiri N, Bonnefond A, Turhan AG, Froguel P, Bennaceur-Griscelli A. Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutation. Stem Cell Res. 2018;29:56\u20139.","journal-title":"Stem Cell Res"},{"key":"1100_CR38","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1002\/hep.26237","volume":"57","author":"SM Choi","year":"2013","unstructured":"Choi SM, Kim Y, Shim JS, Park JT, Wang RH, Leach SD, Liu JO, Deng C, Ye Z, Jang YY. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology. 2013;57:2458\u201368.","journal-title":"Hepatology"},{"key":"1100_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.ejhg.5200182","volume":"6","author":"LA Kluijtmans","year":"1998","unstructured":"Kluijtmans LA, Wendel U, Stevens EM, van den Heuvel LP, Trijbels FJ, Blom HJ. Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur J Hum Genet. 1998;6:257\u201365.","journal-title":"Eur J Hum Genet"},{"key":"1100_CR40","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21:1471\u201382.","journal-title":"Oncologist"},{"key":"1100_CR41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3892\/or.2014.3289","volume":"32","author":"GT Yiang","year":"2014","unstructured":"Yiang GT, Chou PL, Hung YT, Chen JN, Chang WJ, Yu YL, Wei CW. Vitamin C enhances anticancer activity in methotrexatetreated Hep3B hepatocellular carcinoma cells. Oncol Rep. 2014;32:1057\u201363.","journal-title":"Oncol Rep"},{"key":"1100_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.taap.2018.03.023","volume":"346","author":"I Sadeghian","year":"2018","unstructured":"Sadeghian I, Khalvati B, Ghasemi Y, Hemmati S. TAT-mediated intracellular delivery of carboxypeptidase G2 protects against methotrexate-induced cell death in HepG2 cells. Toxicol Appl Pharmacol. 2018;346:9\u201318.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1100_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179995","volume":"12","author":"V Prestigiacomo","year":"2017","unstructured":"Prestigiacomo V, Weston A, Messner S, Lampart F, Suter-Dick L. Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis. PLoS One. 2017;12:e0179995.","journal-title":"PLoS One"},{"key":"1100_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/toxsci\/kfw169","volume":"154","author":"LM Norona","year":"2016","unstructured":"Norona LM, Nguyen DG, Gerber DA, Presnell SC, LeCluyse EL. Editor\u2019s highlight: modeling compound-induced fibrogenesis in vitro using three-dimensional bioprinted human liver tissues. Toxicol Sci. 2016;154:354\u201367.","journal-title":"Toxicol Sci"},{"key":"1100_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","volume":"54","author":"K Begriche","year":"2011","unstructured":"Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol. 2011;54:773\u201394.","journal-title":"J Hepatol"},{"key":"1100_CR46","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.2174\/092986709788803097","volume":"16","author":"S Russmann","year":"2009","unstructured":"Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem. 2009;16:3041\u201353.","journal-title":"Curr Med Chem"},{"key":"1100_CR47","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/adt.2016.729","volume":"14","author":"O Sirenko","year":"2016","unstructured":"Sirenko O, Hancock MK, Hesley J, Hong D, Cohen A, Gentry J, Carlson CB, Mann DA. Phenotypic characterization of toxic compound effects on liver spheroids derived from iPSC using confocal imaging and three-dimensional image analysis. Assay Drug Dev Technol. 2016;14:381\u201394.","journal-title":"Assay Drug Dev Technol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1100-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-1100-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1100-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T19:22:21Z","timestamp":1577560941000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-1100-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-1100-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"20 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the IRB of the Catholic University of Korea (IRB Number: KC13TISI0775). Written informed consent was obtained from all participants involved in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"357"}}